ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,203Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 326

$737K Total Retail Price of All Prescriptions

Rank: 21 out of 326

533 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 533 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

26% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 8,357 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $104 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 660 482 S3 1 1
SIMVASTATIN 369 328 2 2
AMLODIPINE BESYLATE 366 335 3 8
LISINOPRIL 348 301 4 3
LEVOTHYROXINE SODIUM 344 309 5 4
METFORMIN HCL 219 193 6 16
OMEPRAZOLE 201 168 7 5
METOPROLOL TARTRATE 201 160 7 6
GABAPENTIN 192 146 9 17
LOSARTAN POTASSIUM 188 176 10 14
CITALOPRAM HBR 137 117 11 25
BUMETANIDE 130 106 12 92
FUROSEMIDE 126 101 13 7
ATORVASTATIN CALCIUM 123 111 14 10
METOPROLOL SUCCINATE 120 113 15 9
SPIRONOLACTONE 115 104 16 42
TAMSULOSIN HCL 113 104 17 29
POTASSIUM CHLORIDE 106 87 18 21
PREDNISONE 106 85 18 18
PEN NEEDLE 103 71 20 67
DONEPEZIL HCL 97 85 21 34
LANTUS 96 73 22 56
AZITHROMYCIN 92 79 23 54
FLUTICASONE PROPIONATE 91 73 24 22
CARVEDILOL 90 68 25 12
WARFARIN SODIUM 90 66 25 11
SERTRALINE HCL 87 73 27 35
JANTOVEN 85 63 28 179
LEVEMIR FLEXPEN 81 69 29 224
FENTANYL 80 54 S2 30 47
HYDROCHLOROTHIAZIDE 77 69 31 24
PRAVASTATIN SODIUM 73 69 32 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 59 32 57
LANSOPRAZOLE 68 60 34 247
ATENOLOL 65 44 35 13
NAMENDA 65 65 35 49
OXYCODONE-ACETAMINOPHEN 63 54 S2 37 202
IBUPROFEN 62 47 38 62
JANUVIA 59 43 39 134
VERAPAMIL ER 58 57 40 257
LIDODERM 57 57 41 199
LANTUS SOLOSTAR 57 42 41 59
RANITIDINE HCL 55 42 43 43
CELEBREX 55 55 43 131
ADVAIR DISKUS 52 46 45 80
CARBIDOPA-LEVODOPA 52 52 45 58
PLAVIX 51 44 47 39
TRAMADOL HCL 51 35 47 28
CYCLOBENZAPRINE HCL 50 0 R 49 95
ALLOPURINOL 50 48 49 44
PROAIR HFA 50 39 49 100
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.